Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cansativa
Frankfurt am Main, Hessen, Germanycansativa.de ↗
- Ownership
- Private
- Employees
- ~75
- Development stage
- Other
01
Overview
Cansativa is Germany’s largest distributor of medicinal cannabis with exclusive government contracts, over 500 SKUs, 40+ global suppliers, and direct access to 2,500 German pharmacies. In 2023, over 3,000 kg was distributed, with 75% of patients treated for pain. The clinical utility is established through broad patient access to regulated cannabis[2][5][6].
- Therapeutic areas
- OncologyNeurologyOther
- Modalities
- Small moleculePlant-derived therapeutic
- Industry
- Biotech
02
Partnerships
Cronos Inc. (Peace Naturals brand)MedMenOver 40 international suppliers[5]
Beyond the preview
Go deeper on Cansativa.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cansativa.